Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
34.33
-1.81 (-5.01%)
At close: Oct 30, 2026, 4:00 PM EDT
34.23
-0.10 (-0.29%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $9.7 billion as of October 30, 2026. It is the 2,171st most valuable company in the world and the 780th biggest in the United States. Its market cap has increased by 17.22% in one year.
Market Cap
9.70B
Enterprise Value
9.36B
1-Year Change
17.22%
Global Rank
Country Rank
#780 United States
Category
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $9.70B, an increase of 62.92%. That is a compound annual growth rate of 42.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 9.70B | 27.44% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 10.81B |
| Madrigal Pharmaceuticals | 9.94B |
| Krystal Biotech | 9.84B |
| Vaxcyte | 9.76B |
| Twist Bioscience | 9.58B |
| Protagonist Therapeutics | 9.37B |
| Spyre Therapeutics | 9.02B |
| ImmunityBio | 8.79B |